The malignant transformation of cells via the activation of RAS oncogenes has been linked to the acquisition of sensitivity to apoptosis induced by TRAIL (tumour-necrosis factor-related apoptosis-inducing ligand)52, a cytokine involved in cancer immunosurveillance and whose therapeutic potential has been evaluated in clinical trials53. Here, TNFSF10 is linked to cancer.